跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
荃科得 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Capivasertib Tablets
Approved
化学药品
Capivasertib Tablets
ASTRAZENECA UK LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Apr 15, 2025
Approval ID
8jXi22Ms3go
Company
ASTRAZENECA UK LIMITED
Type
化学药品
Approval Details
Approval Id
8jXi22Ms3go
Approval Number
国药准字HJ20250046
Generic Name
卡匹色替片
Generic Name En
Capivasertib Tablets
Trade Name
荃科得
Drug Type
化学药品
Dosage Form
片剂
Strength
160mg
Reg Date
2025-04-15
Expired Date
2030-04-14
Company Name
ASTRAZENECA UK LIMITED
Production Company Name
ASTRAZENECA AB
Company Detail Path
/organization/astrazeneca-uk-limited
Production Company Detail Path
/organization/astrazeneca-ab
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 15, 2025
Approval ID
8jXi22Ms3go
Type
化学药品
Back to NMPA Approvals